MARINUS PHARMACEUTICALS,INC.Files An 8-K Other Events
Item 8.01. Other Events.

On June 13, 2017, the Company’s Board of Directors (the “Board”) determined that it was in the best interest of the Company and its shareholders to designate an independent director to serve in a lead capacity.  The Board appointed Tim M. Mayleben, who is currently a Director of the Company, as Lead Independent Director. The Lead Independent Director’s responsibilities shall include, but are not limited to: (i) in consultation with the CEO determine the frequency, scheduling and agenda structure of Board meetings over the course of the year; (ii) lead executive sessions of the Board’s independent directors; (iii)  advise the independent board committee members and chairs in fulfilling their designated roles and responsibilities to the Board; (iv) provide recommendations for streamlining and improving smooth functioning of the Board; (v) act as a liaison between the independent directors and CEO on sensitive issues; and (vi) advise the CEO on areas of focus for improvement and professional growth.